Interpace Biosciences: Tom Freeburg, Fred Knechtel

Interpace Biosciences has appointed Tom Freeburg as its CFO, succeeding Fred Knechtel effective Feb. 1. Freeburg previously served as chief accounting officer at the firm. Prior to Interpace, he served in senior finance roles at several other firms, including Cambridge Financial Consultants, Coach, Scholastic, and DRS Technologies.